Aston Sci

About:

Aston Sci is a clinical-stage biopharmaceutical company that develops medicines in oncology, immunology, and geriatrics.

Website: http://astonsci.com

Top Investors: Mirae Asset, Mirae Asset Venture Investment, Timepolio Asset Management, Gen-tech Investments, Lakewood Partners

Description:

Total Funding Amount:

27B KRW

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2018-01-01

Founders:

Cwangkwang Chung, Harry Hunwoo Shin, Hun Jung, Ilboo Kim, Jihyun Kim

Number of Employees:

11-50

Last Funding Date:

2021-01-12

IPO Status:

Private

Industries: